MF6.DE

MagForce AG [MF6.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MF6.DE Stock Summary

In the News

MF6.DE Financial details

Company Rating
-
Market Cap
3.49M
Income
-10.57K
Revenue
1.08K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
33
Optionable
No
Shortable
Yes
Earnings
27 Jun 2024
P/E
0
Forward P/E
-
PEG
-
P/S
9.91
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.14
Current Ratio
0.19
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.36
EPS next Y
-
EPS next Q
-
EPS this Y
-70758%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
317.06%
Revenue last 5Y
-13.24%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
-34%
ROC
-0.12%
Gross Margin
-90%
Oper. Margin
-1914%
Profit Margin
-3004%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.11-3.94
52W High
-
52W Low
-
RSI
-
Rel Volume
1.74
Avg Volume
50.74K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
3.018
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
VFINX
3V64.DE
BRH.DE
MSF.DE
NVD.DE
Same Sector
NBLY.TO
WELL.TO
5CV.F
CREO.L
FOLD
Check Those
MAT
BDCZ
MHD
RWX.TO
HRST
Similar Market Cap
ALBA.L
MYRX
HFT.TO
SNIK.L
ORM.L

Company Profile

Healthcare Medical - Instruments & Supplies
  • Volume Average 50.74K
  • Market Capitalization 3.49M
  • Employee 33
  • CEO Dr. Benjamin J. Lipps
  • Headquarters Berlin,DE
  • IPO Date 2007-09-21
  • Website https://www.magforce.com

MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.